PDS Biotechnology Corp (PDSB) reports promising trial results and strategic collaborations, despite financial hurdles and trial amendments.
WASHINGTON (AP) — The House is speeding toward a vote next week on releasing files related to the sex trafficking ...
Company Announced Completion of VERSATILE-002 Phase 2 trial of PDS0101 + Pembrolizumab in HPV16-Positive Recurrent/Metastatic Head and Neck Cancer Phase 2 Results Lead Company to Seek Expedited ...
EAST PRINCETON, N.J. (AP) — EAST PRINCETON, N.J. (AP) — PDS Biotechnology Corporation (PDSB) on Thursday reported a loss of $9 million in its third quarter. The East Princeton, New Jersey-based ...
Rather than simply reading the entire content of the PDF to you, Gemini will provide conversational, podcast-style audio ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback